Search
# Popular search #
0%
# Popular search #
Stock Code
603087.SHGan & Lee’s Insulin Aspart 30 Injection Approved in India
Delegations from Training Programs for Belt and Road Partner Countries Visited Gan & Lee
Gan & Lee Secures Dual Approvals for Insulin Glargine Injection and Prefilled Pen in Honduras
Gan & Lee’s Insulin Glargine Pre-filled Pen Approved in the UAE
Gan & Lee’s Insulin Glargine Injection Approved in Honduras
Gan & Lee Pharmaceuticals Shines at CPHI China 2026, Securing Dual Honors for "R&D Innovation Awards" and "Sustainability Influencer Awards"
To be a world-class pharmaceutical company with focus on global business development
Registered in 23 countries
Products launched in 19 countries
Clinical trials conducted in 10 countries
Registered in 23 countries
Products launched in 19 countries
Clinical trials conducted in 10 countries
This website uses cookies to give users like yourself the best possible content and experience. For more information about your choices regarding cookies, please review our Privacy Policy .
The site you are about to visit is maintained by a third party who is responsible for its content.
This link is provided on the Gan & Lee website as a service to our visitors. Gan & Lee is not responsible for the privacy policy of any third-party websites. Gan & Lee encourages visitors to read the privacy policy of every website that you may visit.
